• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用3D配体形状匹配和配体-受体对接对CXCR4和CCR5受体的HIV进入抑制剂进行基于配体和基于受体的虚拟筛选的比较。

Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.

作者信息

Pérez-Nueno Violeta I, Ritchie David W, Rabal Obdulia, Pascual Rosalia, Borrell Jose I, Teixidó Jordi

机构信息

Grup d'Enginyeria Molecular, Institut Químic de SarriA (IQS), Universitat Ramon Llull, Barcelona, Spain.

出版信息

J Chem Inf Model. 2008 Mar;48(3):509-33. doi: 10.1021/ci700415g. Epub 2008 Feb 26.

DOI:10.1021/ci700415g
PMID:18298095
Abstract

HIV infection is initiated by fusion of the virus with the target cell through binding of the viral gp120 protein with the CD4 cell surface receptor protein and the CXCR4 or CCR5 co-receptors. There is currently considerable interest in developing novel ligands that can modulate the conformations of these co-receptors and, hence, ultimately block virus-cell fusion. This article describes a detailed comparison of the performance of receptor-based and ligand-based virtual screening approaches to find CXCR4 and CCR5 antagonists that could potentially serve as HIV entry inhibitors. Because no crystal structures for these proteins are available, homology models of CXCR4 and CCR5 have been built, using bovine rhodopsin as the template. For ligand-based virtual screening, several shape-based and property-based molecular comparison approaches have been compared, using high-affinity ligands as query molecules. These methods were compared by virtually screening a library assembled by us, consisting of 602 known CXCR4 and CCR5 inhibitors and some 4700 similar presumed inactive molecules. For each receptor, the library was queried using known binders, and the enrichment factors and diversity of the resulting virtual hit lists were analyzed. Overall, ligand-based shape-matching searches yielded higher enrichments than receptor-based docking, especially for CXCR4. The results obtained for CCR5 suggest the possibility that different active scaffolds bind in different ways within the CCR5 pocket.

摘要

HIV感染是通过病毒的gp120蛋白与CD4细胞表面受体蛋白以及CXCR4或CCR5共受体结合,使病毒与靶细胞融合而引发的。目前,人们对开发新型配体以调节这些共受体的构象从而最终阻断病毒-细胞融合有着浓厚的兴趣。本文详细比较了基于受体和基于配体的虚拟筛选方法在寻找可能作为HIV进入抑制剂的CXCR4和CCR5拮抗剂方面的性能。由于这些蛋白质没有晶体结构,因此以牛视紫红质为模板构建了CXCR4和CCR5的同源模型。对于基于配体的虚拟筛选,使用高亲和力配体作为查询分子,比较了几种基于形状和基于性质的分子比较方法。通过虚拟筛选我们组装的一个文库对这些方法进行了比较,该文库由602种已知的CXCR4和CCR5抑制剂以及约4700种类似的假定无活性分子组成。对于每种受体,使用已知的结合剂查询文库,并分析所得虚拟命中列表的富集因子和多样性。总体而言,基于配体的形状匹配搜索比基于受体的对接产生了更高的富集,尤其是对于CXCR4。CCR5的结果表明,不同的活性支架可能以不同的方式结合在CCR5口袋内。

相似文献

1
Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.使用3D配体形状匹配和配体-受体对接对CXCR4和CCR5受体的HIV进入抑制剂进行基于配体和基于受体的虚拟筛选的比较。
J Chem Inf Model. 2008 Mar;48(3):509-33. doi: 10.1021/ci700415g. Epub 2008 Feb 26.
2
Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.通过前瞻性虚拟筛选发现针对CXCR4受体的新型HIV进入抑制剂。
J Chem Inf Model. 2009 Apr;49(4):810-23. doi: 10.1021/ci800468q.
3
Clustering and classifying diverse HIV entry inhibitors using a novel consensus shape-based virtual screening approach: further evidence for multiple binding sites within the CCR5 extracellular pocket.使用基于形状一致性的新型虚拟筛选方法对多种HIV进入抑制剂进行聚类和分类:CCR5细胞外口袋内多个结合位点的进一步证据
J Chem Inf Model. 2008 Nov;48(11):2146-65. doi: 10.1021/ci800257x.
4
Highly specific and sensitive pharmacophore model for identifying CXCR4 antagonists. Comparison with docking and shape-matching virtual screening performance.用于鉴定 CXCR4 拮抗剂的高特异性和高灵敏度药效团模型。与对接和形状匹配虚拟筛选性能的比较。
J Chem Inf Model. 2013 May 24;53(5):1043-56. doi: 10.1021/ci400037y. Epub 2013 Apr 25.
5
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.基于结构的虚拟筛选鉴定非肽类CCR5受体激动剂
J Med Chem. 2007 Mar 22;50(6):1294-303. doi: 10.1021/jm061389p. Epub 2007 Feb 21.
6
Biological profiling of anti-HIV agents and insight into CCR5 antagonist binding using in silico techniques.抗HIV药物的生物学特征分析及利用计算机模拟技术深入了解CCR5拮抗剂的结合情况。
ChemMedChem. 2009 Jul;4(7):1153-63. doi: 10.1002/cmdc.200900101.
7
Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor.深入了解CXCR4受体环五肽拮抗剂的结合模式。
Chem Biol Drug Des. 2006 May;67(5):346-54. doi: 10.1111/j.1747-0285.2006.00387.x.
8
Genotypic coreceptor analysis.基因型共受体分析。
Eur J Med Res. 2007 Oct 15;12(9):453-62.
9
Protein flexibility in ligand docking and virtual screening to protein kinases.用于蛋白激酶的配体对接和虚拟筛选中的蛋白质柔性
J Mol Biol. 2004 Mar 12;337(1):209-25. doi: 10.1016/j.jmb.2004.01.003.
10
Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.在未接受过药物治疗个体血浆中的双嗜性/混合嗜性HIV中,使用趋化因子(C-C基序)受体5的包膜占主导。
AIDS. 2008 Jul 31;22(12):1425-31. doi: 10.1097/QAD.0b013e32830184ba.

引用本文的文献

1
Applying Molecular Modeling to the Design of Innovative, Non-Symmetrical CXCR4 Inhibitors with Potent Anticancer Activity.应用分子建模设计具有强效抗癌活性的创新型非对称 CXCR4 抑制剂。
Int J Mol Sci. 2024 Aug 30;25(17):9446. doi: 10.3390/ijms25179446.
2
Carbazole and tetrahydro-carboline derivatives as dopamine D receptor antagonists with the multiple antipsychotic-like properties.咔唑和四氢咔啉衍生物作为具有多种抗精神病样特性的多巴胺 D 受体拮抗剂。
Acta Pharm Sin B. 2023 Nov;13(11):4553-4577. doi: 10.1016/j.apsb.2023.07.024. Epub 2023 Jul 27.
3
An Agonist of the CXCR4 Receptor Strongly Promotes Regeneration of Degenerated Motor Axon Terminals.
一种 CXCR4 受体激动剂强烈促进退化运动轴突末梢的再生。
Cells. 2019 Sep 30;8(10):1183. doi: 10.3390/cells8101183.
4
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.药物调节 CXCR4 与 BET 溴结构域抑制协同作用于弥漫性大 B 细胞淋巴瘤。
Haematologica. 2019 Apr;104(4):778-788. doi: 10.3324/haematol.2017.180505. Epub 2018 Jun 28.
5
Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis.用于人类趋化因子受体的最大无偏基准数据集及比较分析。
J Chem Inf Model. 2018 May 29;58(5):1104-1120. doi: 10.1021/acs.jcim.8b00004. Epub 2018 May 8.
6
Structural Analysis of Chemokine Receptor-Ligand Interactions.趋化因子受体-配体相互作用的结构分析
J Med Chem. 2017 Jun 22;60(12):4735-4779. doi: 10.1021/acs.jmedchem.6b01309. Epub 2017 Mar 10.
7
Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists.新型小分子CXCR4受体激动剂和拮抗剂的发现与特性研究
Sci Rep. 2016 Jul 26;6:30155. doi: 10.1038/srep30155.
8
Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure.抗HIV小分子在CXCR4:CVX15晶体结构的肽亚口袋中的结合情况。
Chembiochem. 2014 Jul 21;15(11):1614-20. doi: 10.1002/cbic.201402056. Epub 2014 Jul 2.
9
Integrated computational tools for identification of CCR5 antagonists as potential HIV-1 entry inhibitors: homology modeling, virtual screening, molecular dynamics simulations and 3D QSAR analysis.用于鉴定CCR5拮抗剂作为潜在HIV-1进入抑制剂的综合计算工具:同源建模、虚拟筛选、分子动力学模拟和3D QSAR分析。
Molecules. 2014 Apr 23;19(4):5243-65. doi: 10.3390/molecules19045243.
10
Anti-HIV drug development through computational methods.通过计算方法开发抗 HIV 药物。
AAPS J. 2014 Jul;16(4):674-80. doi: 10.1208/s12248-014-9604-9. Epub 2014 Apr 24.